Early experience with minimally invasive direct coronary artery bypass grafting with the internal thoracic artery  by Doty, John R. et al.
and instrumentation continue to evolve. The various
techniques developed for MIDCAB surgery now allow
grafting of all coronary distributions in patients who
need either primary or reoperative procedures. Early
experiences have been reported by several authors.1-4
MIDCAB techniques were developed in an effort to
avoid some of the potential complications of conven-
tional coronary artery bypass grafting by using smaller
incisions, eliminating cardiopulmonary bypass, avoid-
ing manipulation of the great vessels or of existing
grafts, and using arterial conduits. Repeated sternotomy
in particular has inherent risks, including injury to
patent grafts, the heart, and great vessels; embolization
M inimally invasive direct coronary artery bypass(MIDCAB) grafting is being used in an increas-
ingly wider range of patients as operative techniques
Objective: Minimally invasive direct coronary artery bypass is performed
under direct vision without sternotomy or cardiopulmonary bypass. The
technique can be used in both primary and reoperative cases by employ-
ing the internal thoracic artery to perform arterial revascularization of
the anterior surface of the heart. Methods: Patients were selected who
had significant coronary artery disease limited to 1 or 2 coronary dis-
tributions on the anterior surface of the heart. Coronary target vessels
were grafted with the internal thoracic artery through a small anterior
thoracotomy. After partial heparinization the anastomosis was facilitat-
ed by local coronary occlusion and handheld stabilization. Results:
Between August 1994 and July 1997, 162 patients underwent minimally
invasive direct coronary artery bypass grafting with the internal tho-
racic artery. The left and right internal thoracic arteries were used for
grafting of the left anterior descending artery in 142 patients (88%), the
proximal right coronary artery in 7 patients (4%), existing saphenous
vein grafts in 5 patients (3%), and diagonal branches in 2 patients (1%).
Sequential grafting with the left internal thoracic artery was performed
in 2 patients (1%) and bilateral internal thoracic artery grafting was
performed in 4 patients (3%). Eight patients (4.9%) died within 30 days
after the operation, 3 of cardiac causes. Seven additional patients died
during the follow-up period. Nine patients (5.6%) required reinterven-
tion for graft stenosis or occlusion during follow-up. Of 141 patients
seen 2 or more weeks after the operation, 135 (96%) had resolution of
their anginal symptoms at a mean follow-up of 12 months (range 0-31
months). Conclusions: Anterior minimally invasive direct coronary
artery bypass grafting with the internal thoracic artery avoids the risks
of repeated sternotomy, aortic manipulation, and cardiopulmonary
bypass. There was a low rate of reintervention, and patients had excel-
lent resolution of anginal symptoms. Postoperative length of stay was
comparatively short, and continued follow-up will be essential to evalu-
ate long-term graft patency and patient survival. (J Thorac Cardiovasc
Surg 1999;117:873-80)
John R. Doty, MD
James D. Fonger, MD
Jorge D. Salazar, MD
Peter L. Walinsky, MD
Neal W. Salomon, MD
From the Divisions of Cardiac Surgery, Sinai Hospital at Baltimore
and Washington Adventist Hospital, Takoma Park, Md.
Received for publication May 14, 1998; revisions requested July 13,
1998; revisions received Dec 23, 1998; accepted for publication
Dec 30, 1998.
Address for reprints: James D. Fonger, MD, Adventist Heart, 7610
Carroll Ave, Suite 440, Washington Adventist Hospital, Takoma
Park, MD 20912.
Copyright © 1999 by Mosby, Inc.
0022-5223/99 $8.00 + 0 12/1/96851
873
EARLY EXPERIENCE WITH MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFTING
WITH THE INTERNAL THORACIC ARTERY
of atherosclerotic debris from the aorta or diseased vein
grafts; and subsequent wound complications. Conven-
tional coronary artery bypass grafting in reoperative
cases is associated with both prolonged cardiopul-
monary bypass and increased operative times as a result
of more extensive dissection.
This experience demonstrates that minimally inva-
sive techniques that use the internal thoracic artery
(ITA) can result in favorable early patient outcomes,
reduce some of the morbidity associated with conven-
tional coronary artery bypass grafting, and result in a
more rapid recovery after the operation. Long-term out-
comes, however, are necessary for a full evaluation of
the value of the MIDCAB approach.
Patients and methods
Patient selection. Patients were selected in a consecutive
manner for revascularization with MIDCAB grafting of the
ITA if they had significant coronary artery stenosis (>50%
angiographically determined narrowing) limited to 1 or 2
coronary distributions on the anterior surface of the heart. All
patients had symptoms refractory to medical therapy, includ-
ing catheter-based interventions. Exclusion criteria for the
MIDCAB approach included the presence of significant coro-
nary disease in more than 2 coronary distributions and active
myocardial ischemia necessitating intravenous nitrate admin-
istration or mechanical support. Patients were not excluded
on the basis of age, weight, functional status, presence of
functional grafts to other areas of the heart, or other preoper-
ative risk factors, such as previous stroke, previous myocar-
dial infarction, or impaired pulmonary or renal function.
Preoperative demographic data are summarized in Table I.
Operative technique. The patients were prepared for the
MIDCAB operation as for a conventional cardiac operation,
including placement of central venous access, an arterial
pressure monitor, and a urinary drainage catheter. The anteri-
or portion of the chest was prepared and draped as for a con-
ventional cardiac operation, with extended lateral draping on
the side intended for grafting to allow for the small anterolat-
eral thoracotomy.
An 8-cm transverse skin incision was made at the level of
the fourth costal cartilage, just lateral to the sternal border. In
male patients the incision was located above the nipple; in
female patients the incision was placed just above the sub-
mammary fold. The fourth cartilage was released just lateral
to the ITA and reflected inferiorly, or removed in early cases.
Exposure was optimized by means of a conventional retrac-
tion system (Rultract, Inc, Cleveland, Ohio) to simultaneous-
ly elevate the third cartilage and the sternal table. The ITA
was dissected off the chest wall and skeletonized from the
undersurfaces of the first through fifth costal cartilages to
ensure a tension-free anastomosis for left anterior descending
coronary artery (LAD), left anterior descending diagonal
coronary artery (LADD), and proximal right coronary artery
(RCA) targets.
The pericardium was opened longitudinally over the
intended target vessel and 10,000 units heparin was adminis-
tered intravenously. Silicone elastomer retraction tapes
(Quest Medical, Dallas, Tex) were passed around the native
coronary artery proximal and distal to the site of intended
grafting. Heavily diseased coronary targets were not occlud-
ed distally to prevent luminal plaque fracture. One to three 5-
minute cycles of ischemic preconditioning were performed as
required to confirm stable hemodynamics.
An arteriotomy was fashioned in the target vessel and the
conduit was prepared for grafting. Probing of the distal target
vessel was avoided because this may result in vessel wall dis-
section or disruption of plaque when performed on a nonar-
rested heart. The arteriotomy site was stabilized with a hand-
held right-angle clamp with rubber bolsters. The conduit was
anastomosed end to side in an antegrade fashion with a 7-0
polypropylene single parachute suture technique. Intra-
operative graft flow was measured after completion of the
anastomosis with a transit-time ultrasonographic flow probe
(Transonic Systems, Inc, Ithaca, NY) to assist in detection of
technical problems with the anastomosis before closure.
After completion of the anastomosis the ITA pedicle was
secured to the epicardium to ensure proper orientation. A
small suction drain (Hemovac; Zimmer Patient Care
Division, Dover, Ohio) without underwater seal was placed
across the open pericardium and into the pleural space. The
fourth costal cartilage was secured to the sternum with a sin-
gle sternal wire, and a lateral intercostal block was placed
with 0.5% bupivacaine hydrochloride (INN: bupivacaine)
with epinephrine. The muscle and soft tissue were closed in
layers and the drain was secured to the skin.
Patient follow-up. Routine systematic serial cardiac
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Table I. Patient demographics (n = 162)
No. %
Risk factors
Age (y)
Mean 63.8
Range 35-89
Age >65 y 75 46.3
Male gender 98 60.5
Hypertension 111 68.5
Diabetes mellitus 47 29.0
Carotid bruit 10 6.2
Previous cerebrovascular accident 14 8.6
Indications for operation
Angina 147 90.7
Dyspnea 29 17.9
Positive thallium stress test result 79 48.8
Preoperative myocardial infarction 18 11.1
Preoperative catheter-based interventions
Percutaneous transluminal angioplasty 59 36.4
Stent 20 12.3
Rotational ablation 5 3.1
Atherectomy 11 6.8
Any intervention 62 38.3
enzyme analyses were performed at 1 hour, 8 hours, and 16
hours after the operation in all cases, and additional analyses
were performed as indicated. Patients were followed up
prospectively after the operation with clinic visits at 2 weeks
of follow-up, at 3 months of follow-up, and then annually.
Transcutaneous Doppler velocimetric evaluation was per-
formed at 2 weeks, 3 months, and 1 year to assess graft paten-
cy. Exercise thallium stress testing was performed at 3 months
to evaluate improvement in myocardial perfusion in the graft-
ed distribution. Coronary angiography was performed selec-
tively for persistent or recurrent anginal symptoms, for failure
to visualize the graft on subsequent outpatient Doppler veloci-
metric evaluation, or for a significant persistent ischemic
defect on postoperative thallium stress testing.
Results
One hundred sixty-two patients underwent MIDCAB
grafting with ITA during a 35-month period from
August 1994 to July 1997. Mean length of follow-up
was 12 months (range 0 to 31 months); 18 patients
became unavailable for clinical follow-up at varying
intervals. Survival and reintervention statuses are
known for all patients. Operative procedural data
according to conduit and target vessel selections are
summarized in Table II.
Mortality. Eight patients (4.9%) died within 30 days
after the operation; 3 (1.9%) died of cardiac causes.
Seven additional patients (4.3%) had late deaths at
periods ranging from 2 to 21 months after the opera-
tion; 2 (1.2%) died of cardiac causes. Kaplan-Meier
analysis values for patient survival were 92% (95%
confidence interval [CI] 87%-95%) at 12 months and
83% (95% CI 67%-91%) at 24 months (Fig 1). Mortal-
ity data are summarized in Table III.
Morbidity. Seven patients (4.3%) had myocardial
infarction, defined as a creatine kinase MB isoenzyme
value greater than 50 IU on any 2 postoperative mea-
surements. Four patients had undergone primary MID-
CAB grafting and 3 patients had undergone reoperative
MIDCAB grafting. Two of the 7 patients who sustained
myocardial infarction subsequently died. One older
patient who underwent reoperative MIDCAB grafting
had an intraoperative myocardial infarction, presumably
from graft embolization during the initial dissection. An
intra-aortic balloon pump was placed, but the patient
subsequently died on postoperative day 9. The second
patient had a postinfarction ventricular septal defect
develop as a result of graft occlusion; despite operative
repair this patient died on postoperative day 24.
Twenty-two (13.6%) patients had atrial fibrillation or
supraventricular tachycardia develop during the post-
operative period; 20 of the episodes occurred before
discharge. Three (1.9%) patients had stroke or other
significant neurologic impairment. The first patient
died 2 weeks after the operation, after development of
a stroke during hospitalization for pneumonia at anoth-
er institution. The second patient had left-sided weak-
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Table II. Operative conduit and target vessel selection
Procedure and conduit No. Target vessel No.
Primary grafting
LITA 129 LAD 128
LADD 1
Right ITA 7 RCA 6
LAD 1
Reoperative grafting
LITA 19 LAD 13
LAD 1
Existing saphenous 5
vein graft
Right ITA 1 RCA 1
Sequential grafting
LITA 2 LADD, LAD 2
Bilateral grafting
LITA 4 LAD 4
Right ITA 4 RCA 4
Table III. Deaths
No. Age (y) Interval Cause of death
Early cardiac death 
(<30 d after 
operation)
1 89 Intraoperative Cardiac failure
2 81 9 d Myocardial 
infarction
3 71 24 d Myocardial 
infarction
Early noncardiac death 
(<30 d after 
operation)
4 75 2 h Aortic rupture
5 77 15 d Respiratory failure
6 68 17 d Sepsis
7 68 19 d Cerebrovascular 
accident
8 70 27 d Pulmonary embolus
Late death 
(‡ 30 d after 
operation)
9 58 2 mo Arrhythmia
10 45 3 mo Cardiac failure
11 86 2 mo Unknown
12 70 8 mo Unknown
13 87 16 mo Unknown
14 72 18 mo Unknown
15 64 21 mo Cerebrovascular 
accident
ness several hours after discharge on the sixth postop-
erative day; this subsequently resolved. The third
patient had symptoms consistent with transient cerebral
ischemia on postoperative day 2; these symptoms re-
solved spontaneously.
Twenty-four patients (14.8%) had inflammation or
infection develop at the primary operative site. Six
patients (3.7%) had infections that necessitated oper-
ative débridement or revision of the incision. The
remaining 18 patients with infections had inflamma-
tion or minor infections treated in the clinic with
dressings or antibiotics. Most of these wound compli-
cations occurred in patients with submammary inci-
sions. No patient had sternal infection or evidence of
mediastinitis.
Three patients (1.9%) required surgical reexplo-
ration. The first patient was returned to the operating
room twice on the day of operation for bleeding; no site
was found at either exploration. A second patient had
acute graft occlusion immediately after the operation;
reexploration was performed and the graft was revised.
This patient sustained a postinfarction ventricular sep-
tal defect despite these measures, as described previ-
ously. A third patient had early postoperative electro-
cardiographic changes that were treated urgently with
angioplasty of the native LAD. Reexploration the next
morning revealed graft compression by the migrated
lateral edge of the pericardium; release of this impinge-
ment restored normal graft flow.
Fifteen patients (9.3%) required thoracentesis, chest
tube placement, or both for pleural effusion after MID-
CAB grafting. Eight of the patients required this inter-
vention before their discharge from the hospital and in
7 patients the pleural effusion necessitating thoraco-
centesis developed after their discharge.
Conversion to conventional bypass grafting. Ten
patients (6.2%) required conversion to conventional
coronary bypass grafting. Seven of these patients had
primary left ITA (LITA) to LAD grafting, 1 patient had
reoperative LITA to LAD grafting, 1 patient had pri-
mary bilateral ITA grafting to the LAD and RCA, and
1 patient had primary right ITA to RCA grafting.
Indications for conversion to conventional coronary
artery bypass with cardiopulmonary bypass included
hemodynamic instability in 4 cases, arrhythmia in 2
cases, inadequate exposure in 2 cases, ITA dissection in
1 case, and excessive bleeding in 1 case.
Five patients (3.1%) underwent full sternotomy with-
out cardiopulmonary bypass. Three of these patients
underwent primary ITA grafting and 2 underwent reop-
erative grafting. Two of the patients required a full ster-
notomy because of inadequate exposure for grafting
through the MIDCAB incision. One patient required a
full sternotomy during reexploration for bleeding.
Length of stay. Mean overall postoperative length of
stay for all patients was 2.5 days (range 0-27 days).
Mean overall length of stay for all patients except those
who died while in the hospital was 2.2 days (range 1-
12 days).
Recatheterization and reintervention. Twenty-
seven patients (16.7%) underwent postoperative
recatheterization for symptoms, for inadequate graft
flow according to Doppler velocimetric evaluation, for
persistent defect according to thallium stress testing, or
during a planned procedure on another vessel (Table
IV). Fourteen patients had normal grafts and 2 had pro-
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Fig 1. Kaplan-Meier curve (solid line) for patient survival after ITA MIDCAB grafting. Broken lines represent
95% CI. Freedom from death values were 92% (95% CI 87%-95%) at 12 months 83% (95% CI 67%-91%) at 24
months.
gression of native coronary vessel disease at other loca-
tions. Nine patients (5.6%) required reintervention for
stenotic or occluded grafts. Kaplan-Meier analysis val-
ues for freedom from reintervention were 95% (95%
CI, 91%-98%) at 12 months and 92% (95% CI, 82%-
96%) at 24 months (Fig 2).
Four patients (2.5%) had occlusion of the ITA con-
duit. One patient was found to have graft occlusion on
recatheterization 2 days after the operation; the graft
was revised and subsequently reoccluded a second
time. Attempts at percutaneous dilation were unsuc-
cessful on 2 separate occasions. A second patient had a
wound infection that bled after wound revision and
compressed the graft; attempts at percutaneous dilation
were unsuccessful. A third patient was found to have no
diastolic augmentation in the graft according to
Doppler velocimetric evaluation at 5 weeks after the
operation. Recatheterization confirmed graft occlusion,
and attempts at percutaneous dilation were unsuccess-
ful. A fourth patient had recurrent chest pain 1 year
after the operation. Recatheterization demonstrated
graft occlusion, and attempts at percutaneous dilation
were unsuccessful.
Four patients (2.5%) had graft stenoses develop. One
patient had graft impingement by the pericardial edge,
as described previously. Two patients had non–flow-
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Table IV. Recatheterization and reintervention
Postoperative 
Patient interval Operation Findings Result
Normal grafts
16 1 d LITA to LAD Normal
13 1 wk LITA to LAD Normal
17 2 wk LITA to LAD Normal
18 2 mo LITA to LAD Normal
19 2 mo LITA to LAD Normal
20 2 mo LITA to LAD Normal
12 3 mo LITA to LAD Normal
21 4 mo LITA to LAD Normal
14 10 mo LITA to LAD Normal
22 11 mo LITA to LAD Normal
23 11 mo LITA to LAD Normal
24 12 mo LITA to LAD Normal
25 12 mo LITA to LAD Normal
26 12 mo LITA to LAD Normal
Native vessel stenoses 
(remote locations)
27 3 mo LITA to LAD RCA stenosis Successful percutaneous transluminal coronary 
angioplasty
28 8 mo LITA to LAD Distal LAD stenosis No attempt at dilation
Graft occlusions
3 2 d LITA to LAD Occluded Unsuccessful attempt at dilation
9 2 wk LITA to LAD Occluded Unsuccessful attempt at dilation
29 5 wk LITA to LAD Occluded Unsuccessful attempt at dilation
30 13 mo LITA to LAD Occluded Unsuccessful attempt at dilation
Graft stenoses
31 Day of operation LITA to LAD Graft stenosis Successful percutaneous transluminal coronary 
angioplasty and stent
32 1 mo LITA to LAD Graft stenosis No attempt at dilation
33 4 mo LITA to LAD Graft stenosis No attempt at dilation
34 18 mo LITA to LAD Graft stenosis Successful percutaneous transluminal coronary 
angioplasty and stent
Anastomotic stenoses
35 1 mo LITA to LAD Anastomotic stenosis Successful percutaneous transluminal coronary 
angioplasty
4 2 mo LITA to LAD Anastomotic stenosis Successful percutaneous transluminal coronary 
angioplasty
36 3 mo LITA to LAD Anastomotic stenosis Successful percutaneous transluminal coronary 
angioplasty
limiting narrowings in the graft that did not require
reintervention. A fourth patient had a reversible
ischemic defect according to follow-up thallium stress
testing 18 months after the operation. Recatheterization
showed stenosis of the ITA graft, and a stent was suc-
cessfully placed. Three patients (1.9%) had anastomot-
ic stenoses; all stenoses occurred within 3 months after
the operation and were successfully dilated with percu-
taneous methods.
Follow-up. Intraoperative graft flow assessed by
transit-time ultrasonography averaged 23.8 mL/min
(range 1-70 mL/min). Postoperative transcutaneous
Doppler velocimetric analyses of the ITA graft were
performed in 138 cases (85.2%). Three patients had
evidence of decreased flow in the conduit, 2 at the 2-
week examination and 1 at the 5-week examination.
The former 2 patients were both free of symptoms, and
recatheterization was not performed. The latter patient
had graft occlusion on recatheterization, as described
previously. Doppler velocimetric analyses were per-
formed in 122 cases at 2 weeks of follow-up, in 109
cases at 3 months, and in 60 cases at 1 year. Three
patients have had Doppler velocimetric evaluations at 2
years of follow-up; all have evidence of patent grafts.
Thallium stress testing was performed in 106 cases
(65.4%) at 3 months of follow-up. Nineteen patients
were found to have a persistent reversible ischemic
defect, although all grafts evaluated by Doppler veloci-
metric study demonstrated flow. Ten of these patients
underwent recatheterization, 1 had graft occlusion, 2
had anastomotic stenoses, and 2 had native vessel
stenoses, as described in detail previously.
One hundred forty-one (95.9%) of 147 surviving
patients were evaluated for symptoms during clinic vis-
its at 2 weeks of follow-up, at 3 months of follow-up,
and then annually. Of these, 6 (4.1%) had persistent
symptoms and 5 (3.4%) required additional medical
therapy to relieve their anginal symptoms. Antegrade
flow of the ITA conduit was documented by Doppler
velocimetry in 135 (97.8%) of 138 patients studied.
One hundred thirty-five (95.7%) of 141 patients seen in
the clinic had resolution of their symptoms either with
or without additional medical therapy.
Discussion
Revascularization of the LAD with the LITA has
become the standard of care in coronary artery bypass
grafting. Several series with long-term follow-up have
now documented the protective effects of the LITA
with respect to saphenous vein grafting and other con-
duits.5-10 This knowledge was applied to MIDCAB
procedures early in the development of minimally inva-
sive techniques because the LITA lends itself well to
this approach.
This series of patients represents the initial experi-
ence with MIDCAB grafting performed with early
exposure techniques and without currently available
automated mechanical stabilization. In addition, a
selective approach for recatheterization was employed,
which is an inherent weakness of this report.
Nevertheless, this experience is comparable to other
published reports of MIDCAB grafting with the ITA
conduit. Calafiore and associates3 have reported on the
largest series to date (n = 155 patients) of use of the
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Fig 2. Kaplan-Meier curve (solid line) for reintervention after ITA MIDCAB grafting. Broken lines represent 95%
CI. Freedom from reintervention values were 95% (95% CI 91%-98%) at 12 months and 92% (95% CI 82%-
96%) at 24 months.
LITA to graft the LAD, with excellent mortality and
patency rates, and other, smaller series have also
demonstrated encouraging early results.1,2,4,5 In this
series most (7/9) graft stenoses or occlusions necessi-
tating reintervention occurred within 3 months after the
operation. The 3-year follow-up suggests that these
conduits behave as would be expected after successful
graft placement with conventional coronary artery
bypass techniques.
MIDCAB grafting with the ITA has been demon-
strated in some series to carry low attendant early mor-
tality and perioperative infarction rates. In this set of
patients all early deaths were restricted to patients older
than 70 years, and 3 of the 8 deaths were of patients
who underwent reoperation. This suggests that MID-
CAB grafting with the ITA can be most effectively
employed in young, otherwise healthy patients with
single-vessel disease. In contrast, elderly patients with
significant comorbidities and patients undergoing reop-
erative procedures, who are at higher risk with conven-
tional coronary artery bypass, did not have a reduced
risk with MIDCAB in this series. Earlier studies among
patients undergoing conventional coronary artery
bypass procedures examined the role of ITA grafting in
elderly patients and did not associate the use of the ITA
graft with an increased mortality rate among these
patients.8,10 However, a recent study by He and associ-
ates11 of patients undergoing conventional coronary
artery bypass grafting demonstrated that use of the
right ITA and reoperation were among the risk factors
associated with increased early mortality rates among
elderly patients receiving ITA grafts. It is unclear from
this series why the MIDCAB approach did not reduce
the operative risk in this subset of patients.
The MIDCAB approach was effective in reducing
some of the common postoperative complications that
are associated with conventional coronary artery
bypass grafting. There was a low rate of supraventricu-
lar arrhythmia (13.6%), with most (20/22) cases occur-
ring before discharge. There was a small but important
percentage of patients (9.3%) who required thoracente-
sis, chest tube placement, or both for pleural effusion.
Nearly half of these patients had their effusion after
discharge from the hospital or required multiple thora-
cocenteses for recurrent effusion. Both complications
underscore the importance of close follow-up because
arrhythmia or effusion may develop after the patient
has been discharged.
MIDCAB grafting with the ITA did not substantially
reduce the incidence of central nervous system events
(1.9%), as indicated by the 3 patients who had neuro-
logic injury. These injuries occurred despite the avoid-
ance of manipulation of the great vessels and car-
diopulmonary bypass. The causes of these events are
unclear because none occurred within 48 hours after
the operation and none were readily attributed to peri-
operative phenomena.
MIDCAB grafting was associated with a high rate of
wound inflammation or infection (14.8%) in this series
of patients, although most of these complications were
minor. Most of these infections were associated with
the submammary incision. This association prompted
modification to place the incision 1 cm above the infra-
mammary fold and to avoid its use in patients with dia-
betes and those with particularly pendulous breast tis-
sue. Importantly, none of these infections resulted in
sternal infection or mediastinitis, and most patients
required only simple drainage and antibiotics.
Experience with right ITA and bilateral ITA grafting
is accumulating in the MIDCAB setting and further
extends the range of the minimally invasive approach.
Right ITA grafting in conventional coronary artery
bypass has had excellent patency rates when grafted to
the LAD but is also useful in patients without venous
conduits and in isolated proximal RCA disease.12,13
Combined bilateral right and LITA grafting in conven-
tional coronary artery bypass procedures has been
shown to carry good long-term survival and improve-
ment in functional status; it is unclear whether bilater-
al ITA grafting increases surgical risk or infection rates
among these patients.14-17 Four patients in this series
underwent bilateral ITA grafting to the LAD and RCA.
No patient had wound infection, and 1 patient died 3
weeks after the MIDCAB procedure of a pulmonary
embolus after a hip replacement operation. These anec-
dotal results confirm the case report by Watanabe and
associates18 and suggest further investigation into this
technique.
In conclusion, MIDCAB grafting with the ITA is a
versatile operation that results in excellent relief of
patients’ symptoms. Early mortality rates were not as
low as anticipated, however, particularly in the subset
of patients considered to be at higher risk when under-
going conventional coronary artery bypass grafting.
The ITA can be used for isolated grafting of anterior
coronary vessels or for more extensive grafting proce-
dures, including sequential grafting and bilateral ITA
grafting. MIDCAB grafting with the ITA reduces the
incidence of postoperative supraventricular arrhythmia
and reduces postoperative length of stay, allowing
patients to return to normal activity much sooner than
does conventional coronary bypass grafting. Long-term
followup continues to confirm the durability of ITA
grafts placed with MIDCAB techniques.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 5
Doty et al   879
R E F E R E N C E S
1. Acuff TE, Landreneau RJ, Griffith BP, Mack MJ. Minimally
invasive coronary artery bypass grafting. Ann Thorac Surg 1996;
61:135-7.
2. Benetti FJ, Ballester C. Use of thoracoscopy and a minimal tho-
racotomy, in mammary-coronary bypass to left anterior descend-
ing artery, without extracorporeal circulation. J Cardiovasc Surg
1995;36:159-61.
3. Calafiore AM, Di Giammarco G, Teodori G, Bosco G,
D’Annunzio E, Barsotti A, et al. Left anterior descending coro-
nary artery grafting via left anterior small thoracotomy without
cardiopulmonary bypass. Ann Thorac Surg 1996;61:1658-65.
4. Robinson M, Gross D, Zeman W, Stedje-Larsen E. Minimally
invasive coronary artery bypass grafting: a new method using an
anterior mediastinotomy. J Card Surg 1995;10:529-36.
5. Gill IS, FitzGibbon GM, Higginson LA, Valji A, Keon WJ.
Minimally invasive coronary artery bypass: a series with early
qualitative angiographic follow-up. Ann Thorac Surg 1997;64:
710-4.
6. Barner HB, Barnett MG. Fifteen- to twenty-one-year angio-
graphic assessment of internal thoracic artery as a bypass conduit.
Ann Thorac Surg 1994;57:1526-8.
7. Boylan MJ, Lytle BW, Loop FD, Taylor PC, Borsh JA,
Goormastic M, et al. Surgical treatment of isolated left anterior
descending coronary stenosis. J Thorac Cardiovasc Surg 1994;
107:657-62.
8. Gardner TJ, Greene PS, Rykiel MF, Baumgartner WA, Cameron
DE, Casale AS, et al. Routine use of the left internal mammary
artery graft in the elderly. Ann Thorac Surg 1990;49:188-94.
9. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M,
Williams GW, et al. Influence of the internal-mammary-artery
graft on 10-year survival and other cardiac events. N Engl J Med
1986;314:1-6.
10. Wareing TH, Saffitz JE, Kouchoukos NT. Use of single internal
mammary artery grafts in older patients. Circulation 1990;82:
IV224-8.
11. He GW, Acuff TE, Ryan WH, Bowman RT, Douthit MB, Mack
MJ. Determinants of operative mortality in elderly patients
undergoing coronary artery bypass grafting: emphasis on the
influence of internal mammary artery grafting on mortality and
morbidity. J Thorac Cardiovasc Surg 1994;108:73-81.
12. Chow MS, Sim E, Orszulak TA, Schaff HV. Patency of internal
thoracic artery grafts: comparison of right versus left and impor-
tance of vessel grafted. Circulation 1994;90:II129-32.
13. Ramström J, Lund O, Cadavid E, Oxelbark S, Thuren JB, Henze
AC. Right internal mammary artery for myocardial revascular-
ization: early results and indications. Ann Thorac Surg 1993;
55:1485-91.
14. Galbut DL, Traad EA, Dorman MJ, DeWitt PL, Larsen PB,
Kurlansky PA, et al. Bilateral internal mammary artery grafts in
reoperative and primary coronary bypass surgery. Ann Thorac
Surg 1990;49:195-201.
15. Galbut DL, Traad EA, Dorman MJ, DeWitt PL, Larsen PB,
Kurlansky PA, et al. Seventeen-year experience with bilateral
internal mammary artery grafts. Ann Thorac Surg 1990;49:195-
201.
16. Kouchoukos NT, Wareing TH, Murphy SF, Pelate C, Marshall
WG Jr. Risks of bilateral internal mammary artery bypass graft-
ing. Ann Thorac Surg 1990;49:210-9.
17. Cosgrove DM, Lytle BW, Loop FD, Taylor PC, Stewart RW, Gill
CC, et al. Does bilateral internal mammary artery grafting
increase surgical risk? J Thorac Cardiovasc Surg 1988;95:850-6.
18. Watanabe G, Misaki T, Kotoh K, Abe Y, Yamashita A, Ueyama K.
Bilateral minimally invasive direct coronary artery bypass graft-
ing with the use of two arterial grafts. J Thorac Cardiovasc Surg
1997;113:949-51.
880 Doty et al The Journal of Thoracic and
Cardiovascular Surgery
May 1999
